Intervention
total-body irradiation
ClinicalTrials.gov intervention label
Clinical trials
1 shownCommon conditions
Accelerated Phase Chronic Myelogenous Leukemia1Acute Undifferentiated Leukemia1Adult Acute Lymphoblastic Leukemia in Remission1Adult Acute Myeloid Leukemia in Remission1Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities1Adult Acute Myeloid Leukemia With Del(5q)1Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)1Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)1Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)1Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)1Adult Grade III Lymphomatoid Granulomatosis1Adult Nasal Type Extranodal NK/T-cell Lymphoma1Aggressive NK-cell Leukemia1AIDS-related Diffuse Large Cell Lymphoma1AIDS-related Diffuse Mixed Cell Lymphoma1AIDS-related Diffuse Small Cleaved Cell Lymphoma1AIDS-related Immunoblastic Large Cell Lymphoma1AIDS-related Lymphoblastic Lymphoma1AIDS-related Peripheral/Systemic Lymphoma1AIDS-related Primary CNS Lymphoma1AIDS-related Small Noncleaved Cell Lymphoma1Anaplastic Large Cell Lymphoma1Angioimmunoblastic T-cell Lymphoma1Blastic Phase Chronic Myelogenous Leukemia1Childhood Acute Lymphoblastic Leukemia in Remission1
Leading sponsors
Trial status mix
COMPLETED1
Phase mix
NA1
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.